Potential of Neural Stem Cell-Based Therapy for Parkinson’s Disease

作者: Chung-Hsing Chou , Hueng-Chuen Fan , Dueng-Yuan Hueng

DOI: 10.1155/2015/571475

关键词: Parkinson's diseaseNeural stem cellBiologyParacrine signallingBioinformaticsNeurodegenerationJuxtacrine signallingNeuroscienceTransplantationNeurogenesisDopaminergic

摘要: Neural stem cell (NSC) transplantation is an emerging strategy for restoring neuronal function in neurological disorders, such as Parkinson's disease (PD), which characterized by a profound and selective loss of nigrostriatal dopaminergic (DA) neurons. Adult neurogenesis generates newborn neurons that can be observed at specialized niches where endothelial cells (ECs) play significant role regulating the behavior NSCs, including self-renewal differentiating into all neural lineage cells. In this minireview, we highlight importance establishing appropriate microenvironment target site NSC transplantation, grafted integrate surroundings order to enhance DA neurotransmission. Using novel model NSC-EC coculture, it possible combine ECs with generate neurovascular microenvironment. With NSCs selected, composition transplant investigated through paracrine juxtacrine signaling within unit (NVU). cellular acellular compartments recognized, guided differentiation achieved. As differentiated existing pathway, symptoms PD potentially alleviated reversing characteristic neurodegeneration.

参考文章(89)
Ranjita Betarbet, Todd B. Sherer, Gillian MacKenzie, Monica Garcia-Osuna, Alexander V. Panov, J. Timothy Greenamyre, Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nature Neuroscience. ,vol. 3, pp. 1301- 1306 ,(2000) , 10.1038/81834
Rajesh Ambasudhan, Nima Dolatabadi, Anthony Nutter, Eliezer Masliah, Scott R. Mckercher, Stuart A. Lipton, Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells Journal of Comparative Neurology. ,vol. 522, pp. 2845- 2856 ,(2014) , 10.1002/CNE.23617
Seung U. Kim, Hong J. Lee, Yun B. Kim, Neural stem cell-based treatment for neurodegenerative diseases Neuropathology. ,vol. 33, pp. n/a- n/a ,(2013) , 10.1111/NEUP.12020
Uwe Kniesel, Hartwig Wolburg, Tight junctions of the blood-brain barrier. Cellular and Molecular Neurobiology. ,vol. 20, pp. 57- 76 ,(2000) , 10.1023/A:1006995910836
Werner Risau, Mechanisms of angiogenesis Nature. ,vol. 386, pp. 671- 674 ,(1997) , 10.1038/386671A0
J Stone, A Itin, T Alon, J Pe'er, H Gnessin, T Chan-Ling, E Keshet, Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia The Journal of Neuroscience. ,vol. 15, pp. 4738- 4747 ,(1995) , 10.1523/JNEUROSCI.15-07-04738.1995
G. H. Petit, T. T. Olsson, P. Brundin, Review: The future of cell therapies and brain repair: Parkinson's disease leads the way Neuropathology and Applied Neurobiology. ,vol. 40, pp. 60- 70 ,(2014) , 10.1111/NAN.12110
George S Mack, ReNeuron and StemCells get green light for neural stem cell trials Nature Biotechnology. ,vol. 29, pp. 95- 96 ,(2011) , 10.1038/NBT0211-95
Caroline M. Tanner, Freya Kamel, G. Webster Ross, Jane A. Hoppin, Samuel M. Goldman, Monica Korell, Connie Marras, Grace S. Bhudhikanok, Meike Kasten, Anabel R. Chade, Kathleen Comyns, Marie Barber Richards, Cheryl Meng, Benjamin Priestley, Hubert H. Fernandez, Franca Cambi, David M. Umbach, Aaron Blair, Dale P. Sandler, J. William Langston, Rotenone, Paraquat, and Parkinson’s Disease Environmental Health Perspectives. ,vol. 119, pp. 866- 872 ,(2011) , 10.1289/EHP.1002839
Horng-Jyh Harn, Shinn-Zong Lin, Hueng-Chuen Fan, Shyi-Jou Chen, Parkinson's Disease: From Genetics to Treatments: Cell Transplantation. ,vol. 22, pp. 639- 652 ,(2013) , 10.3727/096368912X655082